AU2003248751A1 - Controlled release of anti-arrhythmic agents - Google Patents

Controlled release of anti-arrhythmic agents

Info

Publication number
AU2003248751A1
AU2003248751A1 AU2003248751A AU2003248751A AU2003248751A1 AU 2003248751 A1 AU2003248751 A1 AU 2003248751A1 AU 2003248751 A AU2003248751 A AU 2003248751A AU 2003248751 A AU2003248751 A AU 2003248751A AU 2003248751 A1 AU2003248751 A1 AU 2003248751A1
Authority
AU
Australia
Prior art keywords
controlled release
arrhythmic agents
arrhythmic
agents
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003248751A
Inventor
Arthur J. Coury
C. Michael Philbrook
Kevin C. Skinner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU2003248751A1 publication Critical patent/AU2003248751A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU2003248751A 2002-06-28 2003-06-27 Controlled release of anti-arrhythmic agents Abandoned AU2003248751A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39264202P 2002-06-28 2002-06-28
US60/392,642 2002-06-28
PCT/US2003/020451 WO2004002449A1 (en) 2002-06-28 2003-06-27 Controlled release of anti-arrhythmic agents

Publications (1)

Publication Number Publication Date
AU2003248751A1 true AU2003248751A1 (en) 2004-01-19

Family

ID=30000911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003248751A Abandoned AU2003248751A1 (en) 2002-06-28 2003-06-27 Controlled release of anti-arrhythmic agents

Country Status (3)

Country Link
EP (1) EP1551368A1 (en)
AU (1) AU2003248751A1 (en)
WO (1) WO2004002449A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115364046A (en) * 2022-08-16 2022-11-22 上海交通大学医学院附属第九人民医院 Temperature-sensitive sol for treating vasospasm and preparation method and application thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090220566A1 (en) * 2006-02-01 2009-09-03 Jake Barralet Bioimplants for use in tissue growth
GB201404998D0 (en) * 2014-03-20 2014-05-07 Univ Birmingham Atrial fibrillation therapy
WO2016176333A1 (en) 2015-04-27 2016-11-03 Reflex Medical, Inc. Systems and mehtods for sympathetic cardiopulmonary neuromodulation
US11246879B2 (en) 2016-02-09 2022-02-15 Tulai Therapeutics, Inc. Methods, agents, and devices for local neuromodulation of autonomic nerves
CN110035754A (en) 2016-06-29 2019-07-19 图拉维治疗股份有限公司 Pass through the local nerve adjustment for the treatment of septicemia and the related inflammatory patient's condition of autonomic nerves system
CN117599244A (en) 2018-07-02 2024-02-27 图拉维治疗股份有限公司 Method and apparatus for forming nerve caps in situ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387419A (en) * 1988-03-31 1995-02-07 The University Of Michigan System for controlled release of antiarrhythmic agents
EP0644756A4 (en) * 1993-03-15 1996-02-28 Univ Michigan System for controlled release of antiarrhythmic agents.
ATE319423T1 (en) * 2000-12-27 2006-03-15 Genzyme Corp CONTROLLED RELEASE OF ANTI-ARRHYTHMICS FROM A BIODEGRADABLE HYDROGEL FOR TOPICAL USE ON THE HEART

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115364046A (en) * 2022-08-16 2022-11-22 上海交通大学医学院附属第九人民医院 Temperature-sensitive sol for treating vasospasm and preparation method and application thereof
CN115364046B (en) * 2022-08-16 2024-04-30 上海交通大学医学院附属第九人民医院 Thermosensitive sol for treating vasospasm and preparation method and application thereof

Also Published As

Publication number Publication date
EP1551368A1 (en) 2005-07-13
WO2004002449A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003265866A1 (en) Targeted release
AU2003218151A1 (en) Slow release nitrogen coating
TWI347202B (en) Controlled release preparation
AU2003277576A1 (en) Receptor function controlling agent
AU2002300377A1 (en) Compositions for controlled release
AU2003262059A1 (en) Sustained release preparation
AU2003233465A1 (en) Structural member
IL159048A0 (en) Sustained release formulation
EP1395240A4 (en) Modification of the sustained release profile
AU2002343618A1 (en) Microstructured release liner
AU2002952384A0 (en) Structures
HK1084043A1 (en) Derivatives of aryl-quinazoline/aryl-2amino-phenylmethanone which promote the release of parathyroidhormone
AU2003219814A1 (en) Release agents
AU2002353303A1 (en) Controlling application devices simultaneously
AU2002315122A1 (en) Self-guyed structures
AU2002333819A1 (en) Methods for controlling screenouts
AU2003295355A1 (en) Anchor
AU2003230395A1 (en) Micro-support structures
AU2003244836A1 (en) Suspending agent
EP1273811A3 (en) Fastening means
AU2003284484A1 (en) Drug-sustained release carrier
AU2003248751A1 (en) Controlled release of anti-arrhythmic agents
AU2003290818A1 (en) Topoisomerase-targeting agents
AU2003301877A1 (en) Shaped anchor
AU2002365136A1 (en) Compositions and methods for controlled release

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase